The latest venture capital, seed, pre-seed, and angel deals for London startups for 9/1/2025 featuring funding details for Verdiva Bio, VitVio, and much more. This page will be updated throughout the day to reflect any new fundings.
Verdiva Bio – $411M
Verdiva Bio, a biopharmaceutical company focused on oral and injectable GLP-1 therapies, has raised $411M in Series A funding led by General Atlantic and Forbion Capital Partners. Verdiva Bio was founded by Khurem Farooq and Jane Hughes in 2025.
The London TechWatch audience is driving progress and innovation on a global scale. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including strategic brand placement, lead generation, and thought leadership in front of an audience that comprises the vast majority of key decision-makers in the London business community and beyond. Learn more about advertising to London Tech, at scale.
VitVio – $2M
VitVio, a startup that brings computer vision and AI to surgical operating theaters, has raised $2M in Pre-Seed funding led by LDV Capital. VitVio was founded by Aleksander Pajewski, Maks Kozarzewski, Peter Rennert, and Thomas Knox in 2023.
